The Future of HIV Care TheBodyPro

GLP-1 Agonists and HIV: Do Weight-Loss Drugs Make Sense for Your Patients?
 
 
Three GLP-1 agonist drugs (which originally had been confined to diabetes treatment) are currently FDA approved specifically for weight loss. The rapid uptake of these medications in the U.S. has naturally led to questions within the HIV clinical community about their safety and efficacy in people living with HIV, whose journeys with weight gain and weight loss overlap with the general population but also may differ significantly in a few key ways.
 
 
Joining us on the podcast this month to provide some answers is one of the most prominent clinician researchers exploring this topic today: Grace McComsey, M.D., a professor of pediatrics and medicine at Case Western Reserve University, as well as the vice president of research and the associate chief scientific officer at the University Hospitals Health System in Cleveland, Ohio.
 
 
Read the transcript: https://www.thebodypro.com/article/future-hiv-care-glp-1-agonists-semaglutide
 
 
Credits: Our executive producer is Myles Helfand; our project manager is Alina Mogollon-Volk; our audio producers/engineers are Alex Portaluppi and Lucy Mueller; and our series editors are Maria Elena Perez and Juan Michael Porter II. This episode's audio was edited by Kim Buikema.

For all too many people living with HIV in the U.S., the prospect of facing incarceration because of their status is not an abstraction: It is a real and present danger. And in many states, it has nothing to do with science. This month, Juan Michael Porter II speaks with Joseph Cherabie, M.D., M.Sc., about why it's so important for clinicians to educate themselves about HIV criminalization laws in their state -- and then work to support and empower their patients while pushing to get these laws removed.
 
 
Read the transcript, which includes valuable links to related resources: https://www.thebodypro.com/article/future-hiv-care-criminalization
 
 
Credits: Our executive producer is Myles Helfand; our project manager is Alina Mogollon-Volk; our audio producers/engineers are Alex Portaluppi and Lucy Mueller; and our series editors are Maria Elena Perez and Juan Michael Porter II. This episode's audio was edited by Kim Buikema.

Summer weather is transitioning into sweater weather in most of the U.S., and that means we -- and our patients -- are about to spend a lot more time indoors, inevitably getting exposed to numerous microbes. Accordingly, this month we're talking about vaccinations for people living with HIV: why they're critical, what to consider, how to discuss the topic with your patients, and how to help ensure people living with HIV equitably receive the care they deserve.
 
 
Our guests for this episode, which is hosted by Juan Michael Porter II, are Stella Safo, M.D., M.P.H., of Just Equity for Health and Perry Halkitis, Ph.D., M.P.H., of the Rutgers School of Public Health.
 
 
Read the transcript:
https://www.thebodypro.com/article/future-hiv-care-podcast-vaccinations
 
 
Credits: Our executive producer is Myles Helfand; our project manager is Alina Mogollon-Volk; our audio producers/engineers are Alex Portaluppi and Lucy Mueller; and our series editors are Maria Elena Perez and Juan Michael Porter II. This episode's audio was edited by Kim Buikema.

This month, we’re clearing the air around integrase inhibitors. They are by far the world’s most commonly prescribed HIV drug class -- but that ubiquity has come with long-standing concerns around their potential to cause a range of adverse events, from weight gain to birth defects and more. Our executive editor Myles Helfand speaks with Laura Waters, M.D., FRCP, the head of the British HIV Association, about what the available science tells us.
 
 
Read the transcript: https://www.thebodypro.com/article/future-hiv-care-podcast-integrase-inhibitors-laura-waters 
 
 
Credits: Our executive producer is Myles Helfand; our project manager is Alina Mogollon-Volk; our audio producers/engineers are Alex Portaluppi and Lucy Mueller; and our series editors are Maria Elena Perez and Juan Michael Porter II. This episode's audio was edited by Kim Buikema.

This month, Juan Michael Porter II speaks with Tristan Barber, M.D., FRCP, about the challenges we face in determining the precise causes of particular health complications in people living with HIV. As importantly, they discuss how a provider can best make sense of these challenges and work through them to continue to provide exceptional, supportive patient care.
 
 
Read the transcript: https://www.thebodypro.com/article/future-hiv-care-podcast-treatment-tristan-barber
 
 
Credits: Our executive producer is Myles Helfand; our project manager is Alina Mogollon-Volk; our audio producers/engineers are Alex Portaluppi and Lucy Mueller; and our series editors are Maria Elena Perez and Juan Michael Porter II.

The concept of "patient-centered care" can feel both nebulous and obvious: As a clinician treating a patient, are you not by definition providing patient-centered care? There is a key difference, however, between care that focuses on the patient and care that centers each patient as a unique individual in need of a specifically tailored approach.
 
 
This month, podcast co-hosts Myles Helfand and Juan Michael Porter II dig into this issue, and discuss how conversations about achieving long-term successful health outcomes for people living with HIV must start with the most basic of tenets: Believe your patients, trust them, and show that you’re willing to stand up for their rights to existence and equity.
 
 
Read the transcript, which includes links to the many sources we reference this month: https://www.thebodypro.com/article/future-hiv-care-podcast-trust-your-patients
 
 
Credits: Our executive producer is Myles Helfand; our project manager is Alina Mogollon-Volk; our audio producers/engineers are Alex Portaluppi and Lucy Mueller; and our series editors are Maria Elena Perez and Juan Michael Porter II. Audio for this episode was edited by Kim Buikema.